Shi Yao, Xu Jia-Nan, Wang Qi-Qin, Wang Si-Yuan, Wang Lan-Ying
Department of Obstetrics and Gynecology, Yangming Hospital Affiliated to Ningbo University, Yuyao, Zhejiang, People's Republic of China.
Int J Womens Health. 2025 Jul 12;17:2051-2062. doi: 10.2147/IJWH.S529041. eCollection 2025.
The study aims to develop a model to predict overall survival (OS) in cervical cancer (CC).
A total of 13,592 CC patient records were obtained from the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2020. These patients were randomized with a 7:3 ratio into a training cohort (TC, n = 9,514) and an internal validation cohort (IVC, n = 4,078). Univariate and multivariate Cox regression were used to construct a prognostic model based on the training set and develop a nomogram to predict the 3-year, 5-year, and 10-year OS of CC patients. Additionally, medical data from 318 CC patients at Yangming Hospital Affiliated to Ningbo University, collected between 2008 and 2020, were analyzed for external validation.
Univariate and multivariate Cox regression identified six predictors of prognosis in CC including age, tumor grade, tumor stage, tumor size, lymph node metastasis (LNM), and lymph vascular space invasion (LVSI) to construct the nomogram. The C-index was 0.882 (95% CI: 0.874 to 0.890), and the areas under curves (AUC) for 3-year, 5-year, and 10-year overall survival (OS) were 0.913, 0.912, and 0.906, respectively for the training cohort. The C-index was 0.885 (95% CI: 0.873 to 0.897), and the AUC for the 3-year, 5-year, and 10-year OS were 0.916, 0.910, and 0.910 for the internal validation cohort. For the external validation cohort, the C-index was 0.872 (95% CI: 0.829-0.915), with AUCs of 0.892, 0.896, and 0.903 for 3-year, 5-year, and 10-year OS, respectively.
The devised nomogram can be applied in clinical settings to estimate the OS probability of CC patients. This tool provides personalized predictions for the OS of CC patients, thereby assisting healthcare professionals in optimizing their clinical practices.
本研究旨在开发一种模型来预测宫颈癌(CC)患者的总生存期(OS)。
从2000年至2020年的监测、流行病学和最终结果(SEER)数据库中获取了总共13592例CC患者的记录。这些患者以7:3的比例随机分为训练队列(TC,n = 9514)和内部验证队列(IVC,n = 4078)。使用单因素和多因素Cox回归基于训练集构建预后模型,并开发列线图以预测CC患者的3年、5年和10年总生存期。此外,对宁波大学附属阳明医院2008年至2020年期间收集的318例CC患者的医学数据进行了外部验证分析。
单因素和多因素Cox回归确定了CC患者预后的六个预测因素,包括年龄、肿瘤分级、肿瘤分期、肿瘤大小、淋巴结转移(LNM)和淋巴管间隙浸润(LVSI),以构建列线图。训练队列的C指数为0.882(95%CI:0.874至0.890),3年、5年和10年总生存期(OS)的曲线下面积(AUC)分别为0.913、0.912和0.906。内部验证队列的C指数为0.885(95%CI:0.873至0.897),3年、5年和10年OS的AUC分别为0.916、0.910和0.910。对于外部验证队列,C指数为0.872(95%CI:0.829 - 0.915),3年、5年和10年OS的AUC分别为0.892、0.896和0.903。
所设计的列线图可应用于临床环境中,以估计CC患者的OS概率。该工具为CC患者的OS提供个性化预测,从而帮助医疗保健专业人员优化其临床实践。